These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Travere’s stock price climbed by 14% following the announcement it will seek an FDA label expansion for Filspari.

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

Bernstein analysts led by Florent Cespedes increased their price target on Novo Nordisk (NOVOB:DC) (NYSE: NYSE:NVO) stock to DKK620.00, up from DKK600.00, while maintaining a Market Perform rating.

USA News Group News Commentary – Just weeks after the groundbreaking $500-billion announcement of Project Stargate, which aims to redefine the future of healthcare, industry ...

Morgan Stanley (NYSE:MS) initiated coverage on shares of Novo Nordisk (NOVOB:DC) (NYSE: NYSE:NVO), a global healthcare company specializing in diabetes care and other serious chronic conditions. The ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, recently announced it has completed its acquisition of Ambry Genetics, a ...

Lerodalcibep is an adnectin-based, small protein-binding, third generation proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.

While sleep supplements can be beneficial, the lack of regulation means consumers are not assured of a safe and effective ...

COPD Nutrition Guide: 5 Diet Tips for People with Chronic Obstructive… Your diet can have a significant impact on COPD symptoms and disease progression. Learn… ...